A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
Flu vaccine candidate STEMs the tide
Every year we need a new flu vaccine, because influenza virus constantly mutates the major target of antibodies to flu: the “head” region of the viral hemagglutinin (HA) protein. Avoiding the problem of mutation requires a vaccine that elicits antibodies against the more conserved “stem” region of HA. During infection, antibodies are occasionally produced that recognize the stem and that neutralize a broad range of influenza virus strains. Impagliazzo et al. engineered an HA stem–only vaccine candidate that elicited broadly neutralizing antibodies in mice and nonhuman primates and that protected mice against multiple influenza strains.
Science
, this issue p.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
Vaccines
27 publications, 4.76%
|
|
|
Vaccine
24 publications, 4.23%
|
|
|
Frontiers in Immunology
21 publications, 3.7%
|
|
|
npj Vaccines
18 publications, 3.17%
|
|
|
Viruses
17 publications, 3%
|
|
|
Nature Communications
15 publications, 2.65%
|
|
|
Journal of Virology
14 publications, 2.47%
|
|
|
PLoS ONE
13 publications, 2.29%
|
|
|
Expert Review of Vaccines
13 publications, 2.29%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
13 publications, 2.29%
|
|
|
bioRxiv
11 publications, 1.94%
|
|
|
Scientific Reports
10 publications, 1.76%
|
|
|
PLoS Pathogens
10 publications, 1.76%
|
|
|
Current Opinion in Immunology
10 publications, 1.76%
|
|
|
Cell Reports
8 publications, 1.41%
|
|
|
Immunity
8 publications, 1.41%
|
|
|
mBio
8 publications, 1.41%
|
|
|
Journal of Infectious Diseases
7 publications, 1.23%
|
|
|
Virology
6 publications, 1.06%
|
|
|
Antiviral Research
6 publications, 1.06%
|
|
|
Human Vaccines and Immunotherapeutics
6 publications, 1.06%
|
|
|
Emerging Microbes & Infections
5 publications, 0.88%
|
|
|
eLife
5 publications, 0.88%
|
|
|
Current Opinion in Virology
5 publications, 0.88%
|
|
|
Cell Host and Microbe
5 publications, 0.88%
|
|
|
Science Translational Medicine
5 publications, 0.88%
|
|
|
Science
5 publications, 0.88%
|
|
|
Journal of Experimental Medicine
5 publications, 0.88%
|
|
|
Journal of Immunology
4 publications, 0.71%
|
|
|
5
10
15
20
25
30
|
Publishers
|
20
40
60
80
100
120
140
|
|
|
Elsevier
131 publications, 23.1%
|
|
|
Springer Nature
80 publications, 14.11%
|
|
|
Cold Spring Harbor Laboratory
61 publications, 10.76%
|
|
|
MDPI
51 publications, 8.99%
|
|
|
Taylor & Francis
35 publications, 6.17%
|
|
|
Public Library of Science (PLoS)
26 publications, 4.59%
|
|
|
American Society for Microbiology
26 publications, 4.59%
|
|
|
Frontiers Media S.A.
25 publications, 4.41%
|
|
|
Wiley
22 publications, 3.88%
|
|
|
American Chemical Society (ACS)
18 publications, 3.17%
|
|
|
Oxford University Press
16 publications, 2.82%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
13 publications, 2.29%
|
|
|
American Association for the Advancement of Science (AAAS)
12 publications, 2.12%
|
|
|
eLife Sciences Publications
7 publications, 1.23%
|
|
|
Rockefeller University Press
5 publications, 0.88%
|
|
|
The American Association of Immunologists
4 publications, 0.71%
|
|
|
American Society for Clinical Investigation
3 publications, 0.53%
|
|
|
Mary Ann Liebert
3 publications, 0.53%
|
|
|
IntechOpen
3 publications, 0.53%
|
|
|
Annual Reviews
3 publications, 0.53%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 0.35%
|
|
|
The Royal Society
1 publication, 0.18%
|
|
|
Spandidos Publications
1 publication, 0.18%
|
|
|
Taiwan Institute of Chemical Engineers
1 publication, 0.18%
|
|
|
SPb RAACI
1 publication, 0.18%
|
|
|
Acta Naturae Ltd
1 publication, 0.18%
|
|
|
The Korean Association of Immunobiologists
1 publication, 0.18%
|
|
|
European Molecular Biology Organization
1 publication, 0.18%
|
|
|
American Physical Society (APS)
1 publication, 0.18%
|
|
|
20
40
60
80
100
120
140
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.